CHMP nixes orphan itch treatment Winfuran
This article was originally published in Scrip
Executive Summary
Toray Europe's orphan drug candidate for severe itching in patients with end-stage kidney disease should not be approved for marketing in Europe, the European Medicines Agency's Committee for Medicinal Products for Human Use ( CHMP) has declared.